JDRF-funded clinical trial drug slows Type 1 diabetes in young people
A clinical trial funded by JDRF has found that an existing drug called verapamil slowed the progression of Type 1 diabetes in newly diagnosed children
A clinical trial funded by JDRF has found that an existing drug called verapamil slowed the progression of Type 1 diabetes in newly diagnosed children